Alyson serves as Practice Group Leader for our Pharmaceutical, Medical Device and Healthcare Group. She is well-versed in MDL procedures, having represented major companies in high-profile MDL proceedings. Her recent experience includes serving as co-lead MDL counsel for a major pharmaceutical company in litigation consolidated in the Eastern District of New York and as MDL defense liaison counsel for another major pharmaceutical company in litigation consolidated in the Eastern District of Pennsylvania. ​

Biography – View PDF Bio

Narrative Bio

Adept at coordinating national and local teams of attorneys and non-attorney partners in order to successfully defend against mass torts, Alyson understands the big picture and business implications for her clients, in part due to a three year secundment with a major pharmaceutical company. Her experience involves overseeing and managing all aspects of mass tort litigation including MDL representation, management of bellwether selection, oversight of local counsel, oversight of all pleadings, defensive discovery, and expert development. In addition to her mass tort management capabilities, she has served on numerous trial teams, including Jackson v. McNeil Consumer Healthcare, Case No. ATL-L-880-13, Superior Court of New Jersey, Atlantic County, named one of CVN’s Top 2015 Defense Verdicts. Alyson also serves as discovery counsel in major pieces of pharmaceutical litigation.

Law360 recognized Alyson as one of its 2019 Rising Stars. The Legal 500 US 2018, 2019 and 2020 recognized her as a Next Generation Star (one of only five attorneys recognized across the country), and she is also recognized by Mid-South Super Lawyers (2013-2019), Mid-South Super Lawyers Rising Stars (2010-2012) and Mississippi Business Journal’s Top 40 Under 40 (2014). In 2017, she was selected to PORTICO 10, a group of promising attorneys who have made significant accomplishments in their career. She is a member of the Mississippi Bar Leadership Class (2014) and a graduate of the prestigious International Association of Defense Counsel (IADC) Trial Academy.


Bar Admissions

  • Mississippi, 2004
  • Tennessee, 2004
  • U.S. District Courts
    • Tennessee: Eastern, Middle, Western
    • Mississippi: Northern, Southern

Civic Involvement

  • Friends of Children's Hospital, Board of Directors
  • Century Club Charities, Board of Directors


  • Best Lawyers in America®
    • Product Liability Litigation – Defendants, 2018-2021
  • Law360
  • The Legal 500 U.S.
    • Next Generation Star, 2018-2020
  • 2017 PORTICO 10
  • Graduate, International Association of Defense Counsel (IADC) Trial Academy, Stanford Law School
  • Super Lawyers®
    • Mid-South Super Lawyers, Personal Injury – Products: Defense, 2013-2020
    • Mid-South Rising Stars, Personal Injury – Products: Defense, 2010-2012
  • Top 40 Under 40, Mississippi Business Journal, 2014
  • Mississippi Bar Leadership Class, 2014
  • Life Sciences Star, LMG Life Sciences
  • More...

Education & Honors

  • University of Tennessee, J.D., cum laude, 2004
    • Research Editor, Tennessee Law Review
  • University of Mississippi, B.A., English and Spanish, cum laude, 2001


  • MDL and Mass Tort Management
  • In re: Propecia® (Finasteride) Product Liability Litigation, MDL No. 2331, E.D.N.Y. (Co-Lead Counsel). 
  • In re: Propecia®  Litigation, Case No. 623, Superior Court of New Jersey Law Division: Middlesex County (Co-Lead Counsel).
  • In re: Tylenol®  (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436, E.D. P.a. (Defense Liaison Counsel).
  • Trial Team Support
  • Jackson v. McNeil-PPC, Inc., and Johnson & Johnson, Inc., No. ATL-L-880-13, Superior Court of New Jersey, Atlantic County: Tried in September 2015 - defense verdict; obtained summary judgment dismissing punitive damages.
  • Sessner v. Merck Sharp & Dohme Corp., Superior Court of New Jersey Law Division, Atlantic County: Second New Jersey bellwether product liability case involving prescription drug Fosamax®; defense verdict, 2012.
  • Maley v. Merck Sharpe & Dohme Corp., No. 1:06-cv-04110-JFK, S.D.N.Y., 2010: Second bellwether MDL trial in the Fosamax® litigation.
  • Boles v. Merck & Co., Inc., No. 1:06-cv-09455-JFK, USDC SDNY, 2009: First bellwether MDL trial in the Fosamax® litigation.
  • More...

Papers, Presentations, & Publications